Development, Commercialization and Supply Agreements (Tables)

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Product Approval

The Company received approval of VASCEPA under the MARINE and REDUCE-IT indications in the following countries:

Country	MARINE	REDUCE-IT		Launch Date
Lebanon	March 2018	August 2021		June 2018
United Arab Emirates	July 2018	October 2021		February 2019
Qatar	December 2019	April 2021			—
Bahrain	April 2021	April 2022			—
Kuwait	December 2021		—		—
Saudi Arabia	March 2022		—		—

Changes in Balances of Contract Assets and Liabilities and Revenues Recognized

The following table presents changes in the balances of the Company’s contract assets and liabilities for years ended December 31, 2022 and 2021:

In thousands	Balance at Beginning of Period		Additions		Deductions			Balance at End of Period
Year ended December 31, 2022:
Contract assets	$	—	$	—	$	—		$	—
Contract liabilities:
Deferred revenue	$	16,709	$	6	$	(1,369	)	$	15,346
Year ended December 31, 2021:
Contract assets	$	—	$	—	$	—		$	—
Contract liabilities:
Deferred revenue	$	18,632	$	128	$	(2,051	)	$	16,709

During the years ended December 31, 2022 and 2021, the Company recognized the following revenues as a result of changes in the contract asset and contract liability balances in the respective periods:

In thousands	Twelve Months Ended December 31,
Revenue recognized in the period from:	2022		2021
Amounts included in contract liability at the beginning of the period	$	1,366	$	1,997
Performance obligations satisfied in previous periods	$	2	$	46